
Keywords: AD; Alzheimer's disease; PD; Parkinson's disease; ALS; amyotrophic lateral sclerosis; HD; Huntington's disease; DRPLA; Dentatorubral-pallidoluysian atrophy; NDs; neurodegenerative diseases; In silico study; STRING 9.1 program; Neurodegenerative diseas